STUDY DESIGN OF THE PHASE 3 PORTION OF RISE UP: A PHASE 2/3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Biree Andemariam,
420280
THE LAUNCH OF A GLOBAL, PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM STUDY OF MITAPIVAT IN PATIENTS WITH SICKLE CELL DISEASE AND NEPHROPATHY
EHA Library, Fuad El Rassi,
420281
THE EFFECTIVENESS OF LEVOFLOXACIN IN PREVENTION OF FEBRILE EPISODES IN NON-HODGKIN LYMPHOMA PATIENTS RECEIVING RITUXIMAB, CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN AND PREDNISOLONE (R-CHOP)
EHA Library, Mutita Surakijboworn,
420304
SAFETY, PHARMACOKINETICS, AND EFFICACY OF ELIGLUSTAT ADMINISTERED WITH AND WITHOUT IMIGLUCERASE IN PAEDIATRIC PARTICIPANTS WITH GAUCHER DISEASE TYPE 1 OR 3: THE ELIKIDS STUDY
EHA Library, Pilar Giraldo,
420336